Vyome Holdings, Inc.
NASDAQ: HIND0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ Global Market
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Venkateswarlu Nelabhotla
- Employees
- 18
- Headquarters
- Princeton, United States
- IPO year
- 2016
- Market cap
- $11.8M
- Website
- https://www.vyometx.com
Loading HIND…
Loading profile data…Frequently asked questions about HIND
What does Vyome Holdings, Inc. (HIND) do?
Vyome Holdings, Inc. operates as a healthcare firm currently in its clinical development phase, concentrating on the creation of innovative medicinal treatments designed to address both immuno-inflammatory conditions and infrequent disorders. Founded in 2017, the company extends its market reach throughout the United States and into global terri...
Where does HIND trade?
Vyome Holdings, Inc. (HIND) trades on the NASDAQ Global Market.
What sector is HIND in?
Vyome Holdings, Inc. (HIND) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Vyome Holdings, Inc.?
Venkateswarlu Nelabhotla is the chief executive officer of Vyome Holdings, Inc. (HIND).
Where is Vyome Holdings, Inc. headquartered?
Vyome Holdings, Inc. is headquartered in United States.
Does HIND pay a dividend?
Vyome Holdings, Inc. (HIND) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did HIND go public?
Vyome Holdings, Inc. (HIND) completed its initial public offering in 2016.